SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PLC Systems -- Ignore unavailable to you. Want to Upgrade?


To: John F. Dowd who wrote (615)4/21/1998 4:10:00 PM
From: James A. Winters  Read Replies (2) | Respond to of 1202
 
I too am puzzled by this. I was one of those who made a prediction back in February. I thought that by this time the stock would be at about 23-24 if I remember correctly. Anyway, this indeed may be a sign that FDA either is going to disapprove or is not going to take action this week and someone "knows" this information.

I remember reading the text of the FDA meeting last summer. Unless I misread something I was very surprised to learn that one of the people on the FDA examining board was short PLC shares. I'm glad that pursuant to regulations he had to make that statement but it doesn't seem right to be able to take a position either long or short if one is going to be one of those making a decision on this or any stock. Does anyone else remember reading this?

Jim



To: John F. Dowd who wrote (615)4/21/1998 4:20:00 PM
From: Harami  Read Replies (1) | Respond to of 1202
 
John:

This is not unusual. It went up about the same amount yesterday at about the same volume. Its down today. With the big news coming later in the week, this kind of volatility is not uncommon. Activity this week is not on fundamentals, so I wouldn't read too much into it...



To: John F. Dowd who wrote (615)4/21/1998 5:53:00 PM
From: Larry Southam  Read Replies (3) | Respond to of 1202
 
Forbes Mag issue received today has negative article on PLC in their "Streetwalker" column (issue date May 4).

Nothing new, but says shortsellers are betting "shares will drop by half" after an initial run-up on expected FDA approval. Writer ignores history, efficacy, or any other details.

That's what makes markets!

Larry